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We have developed a methodology for generating
milligram amounts of functional Eph tyrosine kinase
receptor using the protein engineering approach of
expressed protein ligation. Stimulation with ligand
induces efficient autophosphorylation of the semi-
synthetic Eph construct. The in vitro phosphorylation
of key Eph tyrosine residues upon ligand-induced
activation was monitored via time-resolved, quanti-
tative phosphoproteomics, suggesting a precise
and unique order of phosphorylation of the Eph
tyrosines in the kinase activation process. To our
knowledge, this work represents the first reported
semisynthesis of a receptor tyrosine kinase and
provides a potentially general method for producing
single-pass membrane proteins for structural and
biochemical characterization.
INTRODUCTION
Receptor tyrosine kinases (RTKs) control numerous cellular
signaling pathways that regulate the fundamental processes of
cell migration, proliferation, differentiation, and metabolism
(HubbardandTill, 2000;Schlessinger, 2000). As type I transmem-
brane proteins, RTKs consist of an extracellular region, a trans-
membrane helix and an intracellular region that contains a
tyrosine kinase catalytic domain. RTKs have the unique capacity
to transduce the extracellular signal generated on binding to their
cognate ligands, to the cytoplasm by phosphorylating tyrosine
residues on the receptors themselves and on downstream
signaling proteins. Despite the progress over the past several
years in elucidating the molecular details of RTK signaling in
regulating crucial physiological processes, the fundamental
question persists, how is ligand engagement outside the cell
coupled to kinase activation within the cell? A major impediment
in conducting functional and structural studies in vitro is the lack
of efficient recombinant protein expression systems to produce
large amounts of purified transmembrane protein (Drew et al.,
2003). Thus, although one third of our genome codes for integral
membrane proteins (Wallin and von Heijne, 1998), relatively littleChemistry & Biology 18, 3information is available about their three-dimensional structures
and mechanisms. While there have been some important
advances in producingmultipass transmembrane proteins (Jiang
et al., 2003; Kawate and Gouaux, 2006), production of full-length
RTKs in sufficient quantities for biophysical and structural
characterization still remains a major experimental challenge.
This is partially due to the fact that the majority of the multipass
transmembrane protein domains are embedded in the
membrane and can therefore be subjected to much harsher
conditions and also efficiently refolded if necessary. On the other
hand, RTKs only have a single-pass helix embedded in the
membrane, while their disulfide-bonded extracellular region nor-
mally resides in an oxidizing environment, whereas the intracel-
lular region consisting of the catalytic kinase domain resides in
a reducing environment. Indeed, these modular domains can
usually be expressed easily and studied as soluble fragments
individually, using suitable recombinant expression systems,
but not together in a full-length receptor. Thus, our work in this
report is focusedonproducing full-lengthEphRTK for elucidating
the molecular steps in receptor activation.
We focused on the largest family of RTKs, the Eph receptors,
which, together with their membrane-anchored ephrin ligands,
initiate unique bidirectional signaling cascades at sites of cell-
cell contact (Chumley et al., 2007; Kullander and Klein, 2002;
Lackmann and Boyd, 2008; Pasquale, 2005). These signals
regulate cell migration, tissue patterning, axon guidance, devel-
opment of the nervous and the vascular system, learning and
memory, glucose homeostasis, immunological and inflamma-
tory host responses, bone maintenance and remodeling, and
in the development and metastasis of many tumors. The Eph
receptors and ephrin ligands are divided into two subclasses,
A and B, based on sequence homology and their binding
affinities for each other (Eph Nomenclature Committee, 1997).
In general, the A-subclass Eph receptors (EphA1-A10) bind to
the A-subclass ephrins (ephrin-A1-A6), and the B-subclass
Eph receptors (EphB1-B6) interact with the B-subclass ephrins
(ephrin-B1-B3) (Himanen et al., 2007). Like other type I RTKs,
the Eph receptors comprise of an N-terminal disulfide-bonded,
glycosylated ectodomain, which consists of a ligand-binding
domain and an adjacent cysteine rich region followed by two
fibronectin type III repeats. A single transmembrane helix
separates the ectodomain from the intracellular region, which
consists of a juxtamembrane segment, a tyrosine kinase domain61–371, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 361
Figure 1. Summary of the EPL Strategy
Intein-mediated thiolysis generates the Eph ECD a-thioester (I) (LBD: ligand binding domain, CR: cysteine rich region, FN III: fibronectin type III repeat). The intein-
Fc-purification-tag fragment is separated by affinity chromatography. Protease treatment cleaves the SUMO fusion protein with histidine (His) purification tag and
unmasks the cysteine residue at the N terminus of the Eph ICD (II) (JM: juxtamembrane region, Kinase: tyrosine kinase domain; His: purification tag). The two
reactive building blocks I and II are chemically ligated to generate the semisynthetic Eph RTK sans the transmembrane helix (III). See also Figures S1 and S2.
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PDZ-binding motif. The Eph RTK serve as a good model system
for understanding the general biochemical and structural details
of RTK activation.
Cell-based expression systems, both in cells that endoge-
nously express the Eph protein and also genetically engineered
cell lines, have failed to produce high levels of the pure full-length
Eph receptor (Boyd et al., 1992; Dottori et al., 1999; Lawrenson
et al., 2002; Mizushima and Nagata, 1990). Our work presented
here is aimed at overcoming this problem by using a novel chem-
ical biology approach, namely expressing the functional Eph
intracellular and extracellular regions separately in different
expression systems and joining them in vitro using expressed
protein ligation (EPL) (Muir, 2003; Muir et al., 1998). EPL is an
extension of native chemical ligation (Dawson et al., 1994) where
the reacting protein fragments contain either a N-terminal
cysteine or a C-terminal a-thioester, for the semisynthesis of362 Chemistry & Biology 18, 361–371, March 25, 2011 ª2011 Elseviea target protein (Muralidharan and Muir, 2006). We recently
described the utilization of the EPL protein semisynthesis
approach to selectively modify glycosylated and disulfide-
bonded Eph ectodomains secreted from eukaryotic cell lines
(Singla et al., 2008). Here, we present further development of
this method to reconstitute an Eph RTK sans the transmembrane
region and use the generated semisynthetic protein to gain
insight into the mechanism of ligand-induced kinase activation.
RESULTS
Generating Semisynthetic Eph RTK
Our semisynthetic strategy required the generation of an a-thio-
ester derivative of the recombinant Eph extracellular domains
(ECD), which can then be ligated to the recombinant intracel-
lular domains (ICD) containing a cysteine at the N terminus
(Figure 1). The complete EphA4 ECD, which consists of anr Ltd All rights reserved
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lowed by two fibronectin type III repeats, was fused to an engi-
neered version of the Mycobacterium xenopi GyrA intein and
a Fc purification tag. C-terminal intein fusions can be used to
directly introduce a-thioester groups into recombinant proteins
through a thiolysis cleavage reaction (Severinov and Muir,
1998). The fusion construct was expressed as a secreted
protein in insect-cells and was purified from the cell media by
affinity chromatography on Protein-A Sepharose using the Fc
tag. Thiolysis of the intein fusion to introduce the a-thioester
in the EphA4 ECD was initiated with 2-mercaptoethanesulfonic
acid (MESNA) as described previously (Singla et al., 2008).
Structural studies of the Eph and ephrin interaction domains
have shown that complex formation takes place via an exten-
sive interaction interface and that the disulfide bonds on the
extracellular domains of both receptor and ligand are essential
for their correct folding and complex formation (Himanen et al.,
2001). Hence, the biological activity of the EphA4 ECD a-thio-
ester (obtained after thiol treatment) in forming specific high-
affinity complexes with its respective ephrin ligand was estab-
lished using pull-down and size exclusion chromatography
(SEC) binding assays (see Figures S1A and S1B available
online).
The Eph (EphA3 or EphA4) ICD, including the juxtamembrane
and the kinase domains, was expressed as a fusion to the small
ubiquitin-like modifier (SUMO) in Escherichia coli, with histidine
tags included to allow for immobilized metal ion affinity purifica-
tion. SUMO is an 11 kDa protein that covalently attaches to
specific target proteins leading to changes in their function and
activity (Muller et al., 2001; Saitoh et al., 1997). While various
other fusion constructs were tested for recombinant expression
of Eph ICD, the fusion with SUMO, which is known to increase
the expression and solubility of recombinant proteins (Butt
et al., 2005; Marblestone et al., 2006), resulted in the highest
yields. Treatment with ubiquitin-like protein processing enzyme,
SUMO protease, which specifically cleaves conjugated SUMO
from target proteins by recognizing its tertiary structure (Li and
Hochstrasser, 1999; Mossessova and Lima, 2000), leaves a
serine residue at the N terminus of the Eph ICD. As a requisite
for the ligation chemistry, a site directed serine to cysteine muta-
tion was introduced at the N terminus of the Eph ICD; this was
well tolerated and affected neither the expression levels of the
fusion protein nor the protease cleavage efficiency. An important
consideration while designing the semisynthesis reaction is that
the cysteine residue at the ligation junction should be derived
from the native sequence of the protein if possible; otherwise
a conservative mutation should be introduced in a residue that
is not crucial for the function of the protein (Muralidharan and
Muir, 2006; Schwarzer and Cole, 2005). The cysteine residue
at the ligation junction in our constructs corresponds to cysteine
568 in the native EphA3 ICD sequence, and is a serine 574 to
cysteine mutation in case of the EphA4 ICD. The fusion proteins
were treated with SUMO protease, which unmasked the
cysteine residue at the N terminus of the respective Eph ICD.
The cleavage efficiency within 30 min was approximately 90%
(Figure S2A). The SEC profile of the Eph ICD obtained after
cleavage confirmed that it was properly folded and monomeric
(Figure S2B). The efficient and fast cleavage generated high
amounts of reactive Eph ICD and its viability for EPL reactionChemistry & Biology 18, 3was confirmed by ligation with a synthetic peptide a-thioester
(Figure S2C).
Having produced the two recombinant protein building
blocks, the ligation reaction between the EphA4 ECD a-thioester
and the ICD containing a cysteine residue in its N terminus was
performed in the presence of tris(2-carboxyethyl)phosphine
(TCEP) and MESNA, to suppress any competing and unproduc-
tive oxidation and hydrolysis reactions (Dawson et al., 1994;
Muralidharan and Muir, 2006). The concentrations of these
reagents were experimentally adjusted such that they did not
reduce the buried disulfide bonds in the Eph ECD (Himanen
et al., 2001, 2010). The ligation product was partially purified
by SEC, with the only impurity derived from the unligated
EphA4 ECD a-thioester (Figure 2A). The unligated EphA4 ICD
(Mw 36 kDa) elutes separately but the unligated EphA4 ECD
a-thioester (Mw 60 kDa) partially coelutes with the semisyn-
thetic EphA4 receptor (Mw 96 kDa). Therefore, peak fractions
corresponding to the semisynthetic EphA4 receptor and the
unligated EphA4 ECD a-thioester were pooled and a final purifi-
cation was performed using Ni2+ affinity chromatography via the
histidine tag at the C terminus of the semisynthetic EphA4
receptor (Figure 2B). The purified semisynthetic product was
subjected to SEC and resolved on SDS-PAGE revealing lack of
significant impurities (Figure 2C). The SEC profile of the purified
semisynthetic Eph receptor also confirmed that it is monomeric
in solution. Similarly, using the reactive EphA4 ECD a-thioester
and the reactive EphA3 ICD, a chimeric (EphA4ECD-EphA3ICD)
semisynthetic protein was also generated (Figures S3A–S3C).
The production yield for the EphA4 ECD fusion protein
(EphA4ECD-intein-Fc) is 20 mg per liter of cell culture and the
cleavage efficiency (with 50mMMESNA) to generate the reactive
EphA4 ECD a-thioester is approximately 40% (i.e., 8 mg/liter).
The yield for the EphA3 and EphA4 ICD fusion proteins (His-
SUMO-EphA3/A4ICD-His) is15 and12mg/liter, respectively.
The cleavage efficiency with the SUMO protease to unmask the
N-terminal cysteine residue and generate the reactive EphA3
and EphA4 ICD proteins is approximately 90%. The chemical
ligation yield upon mixing the two reactive Eph building blocks
(in a 1:1 ratio) is approximately 50%. Thus, we obtain approxi-
mately 4 mg of the pure, homogenous semisynthetic Eph
receptor from a liter of Eph ECD expression media and 1/2 l of
Eph ICD expression media.
The Semisynthetic Eph RTK Retains the Biological
Activity of Its Individual Domains
Upon optimization of the protocol for production of multimilli-
gram amounts of pure semisynthetic Eph receptor, we con-
firmed that the individual protein domainsmaintained their native
biological activity after the chemical ligation reaction. For the
EphA4 ECD in the semisynthetic receptor, a pull-down binding
assay was performed with ephrin ligand (Figure 3A). The forma-
tion of specific, high-affinity complex with Fc-tagged ephrin-A5
(ephrin-A5-Fc) confirmed that the EphA4 ECD in the semisyn-
thetic protein maintained its correct fold, disulfide-bond pattern,
and ligand binding properties. For the intracellular tyrosine
kinase domain, an enzyme-linked immunosorbent assay
(ELISA)-based kinase assay was performed using a synthetic
poly-Glu-Tyr substrate peptide (Figure 3B). The assay docu-
mented that the Eph kinase domain, maintains a similar61–371, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 363
Figure 2. Semisynthesis of Eph RTK
(A) SEC (size exclusion chromatography) characterization of the products of the chemical ligation reaction. The major peaks I, II, and III correspond to the EphA4
ECD a-thioester (EphA4ECDthio), EphA4 ICD (cys-EphA4ICD-His), and the semisynthetic EphA4 receptor (EphA4ECD-EphA4ICD-His), respectively. An aliquot
of the sample loaded on the SEC column (load) and the fractions under the corresponding peaks are resolved by SDS-PAGE. All shown SDS-PAGEs are
Coomassie stained. (Mw) Molecular weight marker (in kilodaltons).
(B) SDS-PAGE analysis of the semisynthetic EphA4 receptor purification. Fractions corresponding to peaks I and III were loaded on an immobilized metal ion
affinity column (load). The unligated EphA4ECDthio impurity (lacking a histidine tag) is collected in the flow through (load FT) and the wash step (wash FT).
Only the semisynthetic EphA4ECD-EphA4ICD-His protein binds to the column, which is then eluted (elute).
(C) SEC profile for the eluted protein from the affinity column. The fractions under the major peak are resolved on SDS-PAGE and correspond to >95%pure semi-
synthetic EphA4 receptor.
See also Figure S3.
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after ligation. To further characterize the enzymatic properties of
the Eph kinase domain, its affinity for a synthetic biotinylated
poly-Glu-Tyr peptide and ATP substrates was also evaluated
using ELISA. The Km values for ATP (Figure 3C) and for the
peptide substrate (Figure S4) of the EphA3 kinase domain before
and after ligation were comparable, suggesting that the Eph ICD
retains its enzymatic activity after the chemical ligation reaction.
Since, the EphA4 and EphA3 kinase domains are autophos-
phorylated during overexpression, we also performed a western
blot evaluation of the phosphorylation state of the respective
semisynthetic Eph receptors using phosphotyrosine antibody
in the presence and absence of the Yersinia phosphotyrosine
protein phosphatase (YOP) (Black and Bliska, 1997; Guan and
Dixon, 1990), which has high specificity for phosphotyrosines
and broad substrate protein recognition (Zhang et al., 1992) (Fig-
ure 3D). This analysis revealed that (1) phosphorylated tyrosine
residues in the semisynthetic Eph receptor can be specifically
recognized by phosphotyrosine antibodies; (2) using phospha-
tases we can dephosphorylate the protein; and (3) we can
follow the enzymatic activity of the Eph tyrosine kinase domain
resulting in its autophosphorylation in the presence of phospha-
tase inhibitors, ATP and Mg2+. The activity of the kinase domain
of the semisynthetic Eph receptor in transphosphorylating a
peptide substrate both before and after treatment with phospha-
tase, was also evaluated using ELISA (Figure 3E). The reaction
with the phosphatase-treated kinase sample was slower,
presumably because autophosphorylation was required before
the substrate peptide could be phosphorylated. These experi-
ments confirmed that both the autophosphorylation activity of
the tyrosine kinase domain and its ability to efficiently transphos-
phorylate other substrates were maintained in the semisynthetic
Eph receptors.364 Chemistry & Biology 18, 361–371, March 25, 2011 ª2011 ElsevieLigand-Induced Autophosphorylation
of the Semisynthetic Eph RTK
We next sought to monitor in vitro the ligand-induced activation
of the generated semisynthetic Ephs. Specifically, we examined
the autophosphorylation of the tyrosine kinase domain in the
semisynthetic Eph receptors upon addition of the ephrin ligand
in different oligomeric states using two distinct approaches:
a radioactivity-based assay and mass spectrometry. While the
Fc-tagged ephrin (ephrin-Fc) ligand forms dimers that can
induce the formation of active Eph-ephrin tetramers, sufficient
for basal Eph kinase phosphorylation (Himanen and Nikolov,
2003), it has been shown that effective Eph activation under
physiological conditions in vivo requires the multimerization
(clustering) of the Eph/ephrin complexes, which can be achieved
by preclustering of ephrin-Fcwith anti-Fc antibodies (Davis et al.,
1994) (Figure S5A). Hence, the semisynthetic Eph receptor was
incubated with either preclustered or dimeric ephrin-A5-Fc.
The western blot analysis earlier in Figure 3D had shown that
the kinase domain in the semisynthetic Eph receptor is phos-
phorylated. Therefore, the Eph-ephrin complexes were first
incubated with phosphatase, and then with phosphatase inhibi-
tors. The first step dephosphorylated the semisynthetic Eph
protein and the second step inactivated the phosphatase so
that we could follow the phosphorylation upon addition of ATP
and Mg2+. For the radioactivity-based assays, [g32-P] ATP was
added to the above samples and the autophosphorylation of
the kinase was followed over a period of time. The stimulation
of EphA4 receptor autophosphorylation by preclustered eph-
rin-A5-Fc was more efficient than that by dimeric ephrin-A5-
Fc, while it was much slower in the absence of ephrin ligand
(Figure 4A). We also quantified the incorporation of phosphate
in these experiments (Figure S5B). The stoichiometry of the
phosphorylated sites in the semisynthetic EphA4 receptor inr Ltd All rights reserved
Figure 3. Both the ECD and the ICD Retain Full Biological Activity in the Semisynthetic Eph Receptor
(A) The semisynthetic Eph receptor (EphA4ECD-EphA4ICD-His) forms a specific complex with the Fc-tagged ephrin-A5 ligand (ephrin-A5-Fc), which can be
pulled-down by Protein-A Sepharose beads (lane 1). The semisynthetic protein by itself does not bind to the beads (lane 2) whereas the binding of ephrin-
A5-Fc alone to the beads is shown (lane 3). The SDS-PAGE is Coomassie stained. (Mw) Molecular weight marker (in kilodaltons).
(B) Representative plots for the phosphorylation of peptide substrate at different concentration of the unligated (His-SUMO-EphA3ICD-His) (top panel) and ligated
(EphA4ECD-EphA3ICD-His) (lower panel) EphA3 ICD using an ELISA-based assay.
(C) Affinity for ATP of the EphA3 tyrosine kinase. Phosphorylation of a biotinylated peptide substrate by the unligated (His-SUMO-EphA3ICD-His) (top panel) and
ligated (EphA4ECD-EphA3ICD-His) (lower panel) EphA3 ICD was monitored at different concentrations of ATP using an ELISA-based assay. The Km values for
ATP were 110.6 ± 46.9 and 122.8 ± 42.9 mM for the unligated and ligated EphA3 ICD, respectively, comparable to previously reported values (Davis et al., 2008).
(D) Western blot analysis for the semisynthetic Eph protein with EphA4 (EphA4ECD-EphA4ICD-His) (top panel) and EphA3 (EphA4ECD-EphA3ICD-His) (lower
panel) ICD using phosphotyrosine antibody. The semisynthetic proteins are autophosphorylated (lane 1); Treatment with YOP phosphatase dephosphorylates
them (lane 2) and the proteins are not autophosphorylated back upon addition of either Mg2+/ATP (lane 3) or phosphatase inhibitors (lane 4) individually. Simul-
taneous incubation of the dephosphorylated proteins with phosphatase inhibitors andMg2+/ATP results in autophosphorylation of the semisynthetic Eph proteins
(lane 5).
(E) Progress curves for the transphosphorylation of peptide substrate by semisynthetic Eph protein (EphA4ECD-EphA3ICD-His), before (blue) and after (orange)
phosphatase treatment using the ELISA-based assay. Error bars represent the SD of three independent reactions.
See also Figure S4.
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at the 1800 s time point was 4.0 mol of phosphate/mol of
semisynthetic protein. To further confirm that we were observ-
ing ligand-induced increase in Eph autophosphorylation, we
repeated the experiments, in the presence of a peptide Eph
antagonist (K-Y-L-P-Y-W-P-V-L-S-S-L) that selectively inhibits
ligand binding and ephrin-induced autophosphorylation of
EphA4 in vivo (Murai et al., 2003). The boost in the ephrin-
induced autophosphorylation of the semisynthetic Eph receptor
was lost when preincubated with the inhibitor, making it similar toChemistry & Biology 18, 3that observed in the absence of ligand (Figure 4B). These exper-
iments established that we could follow the enzymatic activity of
the kinase domain of our semisynthetic Eph receptor in response
to ephrin binding to its extracellular region.
Monitoring the Phosphorylation of Individual Tyrosines
in the Semisynthetic Eph RTK
To investigate the phosphorylation of individual Eph tyrosine resi-
dues in the semisynthetic receptor in response to ephrin-induced
activation, we next applied label-free relative quantification by61–371, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 365
Figure 4. Kinase Domain Activation in the Semisynthetic Eph Receptor after Stimulation with Ephrin Ligand
(A) Autoradiograph for monitoring the semisynthetic EphA4 receptor (EphA4ECD-EphA4ICD-His) autophosphorylation over a period of time alone or in complex
with dimeric (ephrin-A5-Fc) and preclustered (ephrin-A5-Fc + anti-Fc antibody, Fc-Ab) ephrin ligand. Progress curves were plotted for EphA4 by itself (green), in
complex with dimeric (red) and preclustered (blue) ephrin ligand as quantified using a PhosphorImager.
(B) Loss of ligand-induced autophosphorylation of the semisynthetic Eph receptor in presence of peptide inhibitor. Autoradiograph for monitoring the semisyn-
thetic EphA4 receptor (EphA4ECD-EphA4ICD-His) autophosphorylation over a period of time alone or in complex with dimeric (ephrin-A5-Fc) ephrin ligand in the
presence and absence of a peptide Eph antagonist. Progress curves were plotted for EphA4 by itself (green) and in complex with dimeric ephrin ligandwith (cyan)
and without (red) preincubation with the peptide inhibitor as quantified using a PhosphorImager. Error bars represent the SD of three independent reactions.
See also Figure S5.
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on important individual tyrosine residues that have been
implicated in regulating the catalytic activity of the Eph kinase
domain (Binns et al., 2000; Davis et al., 2008; Wiesner et al.,
2006; Wybenga-Groot et al., 2001). In the case of EphA4, the
phosphorylation of the two-juxtamembrane tyrosine residues,
Y596 (YJM1) and Y602 (YJM2), and of the conserved tyrosine in the
kinase activation loop, Y779 (Yact), play the most important roles
in the activation of the receptor. Hence, these three residues
were monitored in time-resolved phosphoproteomics experi-
ments in the uncomplexed EphA4, and upon binding of dimeric
and preclustered ephrin-A5-Fc (Figure S6A). Tandem mass
spectra (MS/MS) corresponding to the tryptic peptides contain-
ing the phosphorylated juxtamembrane tyrosine residues YJM1
and YJM2, and the activation loop tyrosine Yact were identified
(Figure S6B). Spectral (MS/MS) counts associatedwith individual
phosphorylation of YJM1 and YJM2, respectively, and for their joint
(YJM1+JM2, double) phosphorylation are shown in Figure 5A. The
data reveal that phosphorylation of YJM1 alone is minimal over
the time course of the experiment for all the samples. Significant
phosphorylation of YJM1 is only observed after YJM2 is substan-
tially phosphorylated upon stimulation with ephrin ligand. As
both the juxtamembrane loop tyrosine residues of the semisyn-
thetic EphA4 receptor are present on the same tryptic peptide,
the spectral (MS/MS) counts for their autophosphorylation indi-
vidually and jointly were summed (YJM1(Total) = YJM1 + YJM1+JM2
and YJM2(Total) = YJM2 + YJM1+JM2) to visualize better the total-
autophosphorylation time courses of these tyrosines (YJM1(Total)
and YJM2(Total)) upon activation with preclustered ephrin-A5-Fc
(Figure S7). Analysis of the spectral counts associated with Yact366 Chemistry & Biology 18, 361–371, March 25, 2011 ª2011 Elsevie(Figure 5B) showed that its phosphorylation increased as the
reaction progressed over time and the increase was most signif-
icant after both YJM1 and YJM2 became phosphorylated.
To confirm the critical importance of YJM2 in the kinase activa-
tion process as observed in our mass spectrometry experi-
ments, and as suggested in earlier reports (Binns et al., 2000;
Wybenga-Groot et al., 2001), we used site-directed mutagen-
esis. The ligand-induced kinase autophosphorylation of semi-
synthetic wild-type EphA4 and EphA4 with phenylalanine
substitutions of the juxtamembrane tyrosines was measured
with the radioactivity-based assays (Figure 5C). Significant loss
in the autophosphorylation activity, as compared to the wild-
type protein, was observed when YJM2 was mutated, but not
when YJM1 alone was substituted.
DISCUSSION
EPL has been previously used to modify intracellular and multi-
pass transmembrane proteins that can be folded to the native
state after the chemical ligation reaction (Valiyaveetil et al.,
2002), but its application to RTKs with large multidomain extra-
cellular and intracellular regions normally residing in different
redox environments, has not been documented. We now report
the development of this semisynthetic technique to reconstitute
an Eph RTK where all functional domains fully retain their biolog-
ical activity. The production of multimilligram amounts of pure
and monodisperse semisynthetic Eph receptors, made possible
by this technology, provide a unique opportunity for their struc-
tural and mechanistic analysis in vitro to answer fundamental
questions regarding their molecular mechanism of action. Inr Ltd All rights reserved
Figure 5. Analysis of the Phosphorylation Time Courses Of Individual Tyrosine Residues in the Semisynthetic Eph Receptor after Stimulation
with Ephrin
(A) Phosphoproteomics analysis. The phosphorylation levels of the semisynthetic receptor juxtamembrane loop tyrosine residues were quantified using MS/MS
spectral counts. Progress curves for the autophosphorylation of the individual juxtamembrane tyrosine residues (YJM1 and YJM2) alone, as well as for their joint
phosphorylation, YJM1+JM2, in the absence or presence of dimeric and preclustered ephrin ligand are colored as indicated.
(B) Progress curves for the autophosphorylation of the activation loop tyrosine residue, Yact, in the semisynthetic receptor quantified using MS/MS spectral
counts, in the absence (green) or presence of dimeric (red) and preclustered (blue) ephrin ligand. For each time point, the experimental data from three technical
LC-MS/MS replicates performed on same amount of substrate was merged.
(C) Ligand-induced autophosphorylation of semisynthetic Eph receptors, wild-type (WT) and those with juxtamembrane tyrosine mutations (YJM1F, YJM2F and
YJM1+JM2F). Autoradiographs were quantified with PhosphorImager and are colored as indicated. Error bars represent the SD from three independent reactions.
See also Figures S6 and S7.
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the phosphorylation timelines of the individual Eph tyrosines can
be extended further to investigate, for example, the differences
in activation of the different promiscuous Eph family members
in response to binding of different A and B class ligands (Bowden
et al., 2009; Gale et al., 1996). The reported method should be
general enough to be easily applicable to many other multido-
main receptors allowing the production of large amounts of
various functional cell-surface proteins for structural studies
using X-ray crystallography and cryoelectron microscopy.
The generation of the semisynthetic EphA4 receptor provided
a means to monitor the phosphorylation of its individual tyrosine
residues during the ligand-induced kinase activation process.
Our mass spectrometry experiments suggest that Eph receptors
are activated upon ephrin binding via a sequential and ordered
autophosphorylation process where YJM2 is phosphorylatedChemistry & Biology 18, 3first, followed by YJM1, and, finally by Yact. This is in contrast
with observations for most other receptor kinases where the
kinase activation loop is phosphorylated first. The most detailed
such study involved the tyrosine kinase domain of FGF-
Receptor-1, for which K. Anderson and colleagues reported
a sequential phosphorylation mechanism where one of the two
activation loop tyrosines (Y653) is always the first tyrosine phos-
phorylated, while a juxtamembrane tyrosine is phosphorylated
late in the activation process (Furdui et al., 2006; Lew et al.,
2009). Similar kinase phosphorylation sequences, always begin-
ning with activation loop phosphorylation, have also been
suggested for the IR, IGFR, Tie2, and MuSK receptor kinases
(discussed in detail in Furdui et al., 2006). The fact that in
EphA4 the activation loop tyrosine is phosphorylated only after
the juxtamembrane tyrosines underlies its unique signaling prop-
erties and the notion that the different receptor kinase families61–371, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 367
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and inhibition. Importantly, in contrast to previous studies (Furdui
et al., 2006; Lew et al., 2009), the reported here method allows
the monitoring of ligand-induced kinase phosphorylation in a
construct containing not only the intracellular, but also the extra-
cellular (ligand binding) region of the receptors.
Our experiments reveal another unique Eph characteristic: the
observed phosphorylation time-dependences suggest that the
Eph kinase activity most closely correlates with the phosphory-
lation status of the juxtamembrane region and not that of the
activation loop, as is the accepted view for most other character-
ized protein kinases (Hubbard and Till, 2000; Huse and Kuriyan,
2002; Schlessinger, 2000). Furthermore, our mutagenesis exper-
iments show that the Eph kinase activity is primarily correlated
with phosphorylation of YJM2 and not of the adjacent YJM1. Inter-
estingly, studies have shown that Eph signaling can be regulated
by protein tyrosine phosphatases that specifically dephosphory-
late YJM2 (Shintani et al., 2006), further supporting an important
role for this site in vivo. Our observations are also consistent
with structural studies of the Eph kinase and juxtamembrane
domains, showing that phosphorylation of the Eph activation
loop does not significantly affect the architecture of the active
site, whereas the conformation of the juxtamembrane region
can alter the molecular dynamics of the kinase (Wiesner et al.,
2006), and thus presumably its enzymatic activity. We are
currently working on incorporating the 25 residue membrane
sequence in the semisynthetic Ephs, whichwill allow for studying
its precise role in the receptor activation mechanism, but we do
not expect to see a change in the reported here order of indi-
vidual tyrosine phosphorylation. The PDGF RTKs are also regu-
lated by juxtamembrane region phosphorylation, but structural
studies of c-Kit (Mol et al., 2004) and FLT3 (Griffith et al., 2004)
suggest that there it is still the activation loop conformation
that defines the kinase activity, while phosphorylation of the
juxtamembrane regions removes a physical obstacle allowing
the activation loop to adopt its active/open conformation for
catalysis.
SIGNIFICANCE
While significant progress has been made in understanding
how receptor tyrosine kinases regulate important cellular
signaling pathways, a major challenge in conducting
in vitro studies to elucidate the molecular details of the
ligand-induced kinase activation is the lack of recombinant
expression systems to produce large amounts of pure full-
length proteins. Our work described here is aimed at over-
coming this problem by development of a semisynthetic
method to reconstitute functional Eph receptor tyrosine
kinases in large amounts for structural and functional
studies. Phosphoproteomics-based studies on such a semi-
synthetic Eph protein provide novel insight into the unique
order of phosphorylation of individual phosphotyrosine resi-
dues in the ligand-induced kinase activation mechanism.
The semisynthetic technique developed and described in
this study could serve as a generalmethod for reconstituting
and studying the biochemical and structural details of
receptor tyrosine kinases and other cell-surface receptors.
Considering the importance of these molecules as drug368 Chemistry & Biology 18, 361–371, March 25, 2011 ª2011 Elsevietargets in many diseases, our study should make significant
contributions both in answering fundamental questions
about signal transduction mechanisms and toward the
discovery of novel therapeutics.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The PCR amplified cDNA sequence corresponding to the ECD of human
EphA4 (residues Glu30Thr547) was cloned into a modified pAcGP67-B
Baculovirus vector (BD PharMingen). The vector is under the control of the
GP67 signal sequence and contains a C-terminal Fc (human IgG1 hinge and
Fc regions) purification tag. The Mxe GyrA intein (198 amino acids) from the
pTXB1 vector (New England Biolabs) was PCR amplified and fused in frame
to the C terminus of EphA4 ECD between the ECD and the Fc purification
tag. This intein with a C-terminal Asn / Ala mutation, promotes only the
first step of protein splicing (Xu and Perler, 1996). The fusion construct
(EphA4ECD-intein-Fc) was sequenced (Genewiz), and the recombinant bacu-
lovirus vector was cotransfected with BaculoGold DNA (BD PharMingen) in
insect cells and expressed as previously described (Singla et al., 2008). The
ectodomain of the human ephrin-A5 (residues 1228) was cloned N-terminally
to a thrombin cleavage site and the Fc region of IgG1 in a modified pcDNA3.1
vector (Invitrogen). The fusion construct (ephrin-A5-Fc) was constitutively
expressed in a HEK293 (human embryonic kidney) cell line using the CD5
signal sequence as previously described (Barton et al., 2005). The secreted
fusion proteins were extracted from the medium by affinity chromatography
using Fast Flow Protein-A Sepharose (GE Healthcare). When required, the Fc
tag was removed from ephrin-A5 by thrombin cleavage (1 U/mg of fusion
protein) and it was purified by gel-filtration chromatography. The cDNA
sequence corresponding to the juxtamembrane region and kinase domain
of the human EphA3 (residues Gly569Lys889) and EphA4 (residues
Lys575Ser896) receptors was PCR amplified and cloned C-terminally to
a SUMO protease cleavage site in a modified pET SUMO vector (Invitrogen).
The site-directed Ser/ Cys mutation and insertion of the polyhistidine tag
was performed with the QuickChange Mutagenesis Kit (Stratagene) at the N
and C terminus of the EphA3/A4 ICD, respectively. The fusion constructs
(His-SUMO-EphICD-His) were sequenced (Genewiz) and transformed into
E. coli BL21-Gold (DE3) cells (Stratagene). Cells were grown in LB supple-
mentedwith kanamycin at 37C to anOD600 of 0.5–0.6 andwere induced over-
night at 18Cand1mMIPTG. Theproteinswere purifiedonaHisTrapHPNickel
Sepharose column (GEHealthcare). The two-juxtamembrane tyrosine residues
for EphA4 ICD were mutated to phenylalanine, individually and together, using
the QuickChange Mutagenesis Kit (Stratagene). These three fusion constructs
were then expressed and purified using the above protocol. The plasmid for
YOP (YopH) phosphatase was provided by Dr. Markus A. Seeliger, it was
expressed and purified as previously described (Seeliger et al., 2005).
Generation of EphA4 ECD a-Thioester and EphA3/A4 ICD
with Reactive Cysteine
The purified EphA4ECD-intein-Fc fusion protein was bound to Protein-A
Sepharose beads. The beads were re-suspended as 50% slurry into thiol
cleavage buffer containing 100 mM HEPES (pH 7.5), 300 mM NaCl and
1mMEDTA. Thiol agent MESNAwas added at 50mM and the slurry was incu-
bated overnight at 4C. The cleaved EphA4 ECD a-thioester was collected in
the supernatant. The purified EphA3/A4 ICD were dialyzed into thiol cleavage
buffer with 1 mM DTT and incubated with SUMO protease in a 1:400 (w/w)
protease-to-protein ratio and 3 mM TCEP at 4C for 1 hr, generating the reac-
tive cysteine at the N terminus. The Eph ICD obtained after cleavage was
loaded onto a Superdex-200 10/30 gel-filtration column (GE Healthcare) pre-
equilibrated with a buffer containing 20 mM HEPES (pH 7.2) and 150 mM
NaCl. The Eph ICDs were ligated to a synthetic peptide with a C-terminal
a-thioester (synthesized by T.W.M.). The peptide (M-A-R-T-K-Q-T-A-R-K-
S-T-G-G-K-A-P-R-K-Q-L-A-T-K-A-A-R-K-S-A-P-A) was dissolved in thiol
cleavage buffer with 50 mM MESNA. The ligation reaction was performed by
incubating overnight an excess of the peptide with freshly obtained reactive
Eph ICD in ligation buffer containing 100 mM HEPES (pH 8.4) and 10 mM
MESNA at 4C.r Ltd All rights reserved
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The purified reactive EphA4 ECD a-thioester, obtained following thiol
cleavage, and the reactive EphA4/A3 ICD, obtained after protease treatment,
were concentrated (tomillimolar range) andmixed in a 1:2molar ratio. The liga-
tionmixture was incubated for 48 hr at 4C in ligation buffer containing 100mM
HEPES (pH 8.4), 50 mM MESNA, and 3 mM TCEP. The reaction was then
loaded onto a Superdex-200 10/30 gel-filtration column (GE Healthcare) pre-
equilibrated with a buffer containing 20 mM HEPES (pH 7.2) and 150 mM
NaCl. The fractions corresponding to the semisynthetic Eph receptor and
unligated Eph ECD a-thioester were pooled and buffer-exchanged into equil-
ibration/wash buffer containing 50 mM Tris-HCl (pH 8.0), 30 mM imidazole,
300mMNaCl, and 1mMTCEP. The protein sample was loaded onto a HisTrap
HP Nickel Sepharose column pre-equilibrated with the above buffer after
which the column was washed with the same buffer. The bound protein was
eluted with elution buffer containing 50 mM Tris-HCl (pH 8.0), 300 mM imid-
azole, 300 mM NaCl, and 1 mM TCEP. The eluted protein was loaded onto
a Superdex-200 10/30 gel-filtration column pre-equilibrated as mentioned
above. The fractions corresponding to the pure semisynthetic Eph receptor
were pooled and stored at 80C in a buffer containing 20 mM HEPES
(pH 7.2), 150 mM NaCl, 1 mM TCEP, and 15% glycerol. The semisynthetic
EphA4 receptor variants with the different juxtamembrane tyrosine mutations
were obtained by the chemical ligation of the purified EphA4 ECD a-thioester
with the respective EphA4 ICD mutant, using the above protocol.
Pull-Down and Gel-Filtration Ligand Binding Assays
The EphA4 ECD a-thioester, obtained following thiol cleavage and the semi-
synthetic Eph receptor, obtained after purification were incubated with Fc-
tagged ephrin-A5 ligand in a 1:1 molar ratio. The pull-down experiments
were performed as previously described (Singla et al., 2008). Gel-filtration
studies for the EphA4 ECD a-thioester, purified ephrin-A5 ligand and the
complex of both in a 1:1 molar ratio, were performed as previously described
(Singla et al., 2008).
ELISA assay and Western Blotting
A nonradioactive kinase assay was performed using the ELISA-based protein
tyrosine kinase assay kit (PTK101, Sigma). The unligated Eph ICD and the
semisynthetic Eph receptor proteins in increasing concentration were incu-
bated with Mg2+ and ATP for 30 min on wells coated with poly-Glu-Tyr peptide
substrate. The phosphorylated peptide substrate was detected by ELISA
using monoclonal HRP conjugated phosphotyrosine antibody and HRP chro-
mogenic substrate. Optical density of each well was determined at 490 nm in
a multiwell plate reader (Victor X5, PerkinElmer). Reagent preparation and
detailed protocol were followed from the manufacturer’s instructions. The
semisynthetic Eph receptor was incubated with YOP phosphatase for 3 hr fol-
lowed by overnight incubation with phosphatase inhibitor cocktail 2 (Sigma) at
4C. Equal amounts of semisynthetic protein (10.4 nM) before and after phos-
phatase treatment were added to the substrate-coated wells in presence of
Mg2+and ATP. The kinase activity of both was monitored over a period of
time using the ELISA assay described above. A synthetic peptide substrate
[GG(EEEEY)10EE] conjugated to biotin at its N terminus (Millipore), Mw =
7413 daltons, was used in the ELISA assay for the Km measurements. To
measure the Km for the biotinylated peptide substrate, the concentrations of
ATP, the unligated Eph ICD, and the semisynthetic Eph receptor proteins,
were kept constant at 250 mM, 11 nM, and 10.4 nM, respectively, whereas
the concentration of the peptide was varied from 0 to 25 mM. To measure
the Km for ATP, the concentrations of the biotinylated peptide substrate, the
unligated Eph ICD, and the semisynthetic Eph receptor proteins, were kept
constant at 5 mM, 11 nM, and 10.4 nM, respectively, whereas the ATP concen-
tration was varied from 0 to 500 mM. The enzyme reactions were incubated for
5 min at 30C and then quenched with 100 mM EDTA. Thereafter, the reaction
mix was immobilized by binding to the preblocked streptavidin coated plates
(Pierce). The phosphorylation of the biotinylated peptide substrate was visual-
ized by ELISA using a phosphotyrosine monoclonal antibody conjugated
to HRP and an ensuing chromogenic substrate reaction as described
above. Km values were calculated using the Michaelis-Menten equation using
GraphPad Prism version 5.0a. For the western blot experiments, the semisyn-
thetic Eph receptor was dephosphorylated by incubation with YOP phospha-
tase for 3 hr at 4C and autophosphorylated back by simultaneous treatmentChemistry & Biology 18, 3with phosphatase inhibitor cocktail 2 (Sigma) for 2 hr and a buffer containing
30 mMHEPES (pH 7.5), 20 mMMgCl2, and 10 mM ATP for 2 hr at 4
C. Protein
samples were resolved on SDS-PAGE, electroblotted onto polyvinylidene
difluoride membrane (BioRad), blocked with 2% fat free milk in TBST (0.5%
Tween 20, 1.5 M NaCl in 100 mM Tris-HCl [pH 8.0]) and incubated overnight
with the monoclonal phosphotyrosine antibody (4G10, Upstate Biotech-
nology). After rinsing with TBST, the membrane was incubated for 1 hr with
the alkaline phosphatase (AP) conjugated secondary antibody (Promega).
The AP was visualized with NBIT/BCIP substrate tablets (Roche).
In Vitro Kinase Assays
The disulfide-linked immunoglobulin Fc-tag results in formation of the dimeric
ephrin-A5-Fc ligand. Ephrin-A5-Fc was clustered by overnight incubation with
monoclonal anti-human IgG1 (anti-Fc) antibody (Jackson ImmunoResearch) in
a 1:2 (w/w) ratio at 4C to generate multimeric ephrin. For monitoring the
ligand-induced kinase activity in the semisynthetic EphA4 receptor, equal
quantity of the receptor was incubated with dimeric and pre-clustered ephrin-
A5-Fc in a 1:1molar ratio for 7 hr at 4C, in the tyrosine kinase buffer containing
30 mM HEPES (pH 7.5), 20 mM MgCl2, 1 mM MnCl2, and 0.1 mg/ml bovine
serum albumin. This was followed by incubation with YOP phosphatase for
5 hr at 4C, and overnight incubation with phosphatase inhibitor cocktail 2
(Sigma) at 4C. The reaction mixture was preincubated at 30C for 5 min,
and 0.3 mM ATP plus [g32-P] ATP (14.5 mCi) was added to start the reaction.
The reaction mixture was incubated at 30C and equal aliquots were with-
drawn over a period of time for each of the three samples and terminated by
adding Laemmli buffer. Reaction samples were resolved on SDS-PAGE, which
were dried and exposed to a PhosphorImager screen (GE Healthcare). The
[g32-P] ATP incorporation was quantified using ImageQuant software. The
[g32-P] ATP incorporation in the semisynthetic EphA4 receptor with the juxta-
membrane tyrosine mutations (YJM1F, YJM2F and YJM1+JM2F) on stimulation
with dimeric ephrin-A5-Fc ligand, was also monitored using the radioac-
tivity-based kinase assay described above. For measuring the stoichiometry
of phosphate incorporation, a similar experimental set-up as described above
was used. Reaction products were resolved on SDS-PAGE. Individual bands
were excised, dissolved in 30% H2O2 (Sigma) and the incorporation of phos-
phate on tyrosine residues was measured using a liquid scintillation counter.
For monitoring the kinase activity in the presence of the peptide Eph inhibitor,
the peptide (synthesized by Biopeptide Inc.) was dissolved in peptide buffer
containing 8% DMSO, 20 mM HEPES (pH 8.4), 150 mM NaCl, and 2 mM
MgCl2. The semisynthetic EphA4 receptor was incubated overnight with
excess of the peptide inhibitor at 4C along with two control reactions
comprising of equal quantity of the semisynthetic receptor in peptide buffer.
Dimeric ephrin-A5-Fc ligand was added to the receptor-peptide mix and to
one of the control reactions. Using an experimental setup as described above
the incorporation of labeled ATP was measured for the three samples.
Label Free Phosphoproteomics Analysis
Using a similar experimental set-up as described above with only 0.3 mM of
unlabeled ATP for starting the reaction, nano-liquid chromatography coupled
to mass spectrometry (nano-LC-MS/MS) analysis was performed to monitor
the autophosphorylation of the semisynthetic Eph receptor by itself, and
upon binding to dimeric and preclustered ephrin-A5-Fc ligand. The bands
for the semisynthetic Eph protein were excised from the SDS-PAGE and
digested overnight with trypsin as previously described (Sebastiaan Winkler
et al., 2002). Resulting tryptic peptides were subjected to a micro-clean-up
procedure as previously described (Erdjument-Bromage et al., 1998), and
diluted with 0.1% formic acid. Analysis of the batch-purified pools was done
using an LTQ OrbiTrap XL (Thermo Scientific) mass spectrometer with
a nano-electrospray ion (ESI) source coupled to an Eksigent nano-LC system
(Eksigent Technologies). For each time point, three technical LC-MS/MS repli-
cates were performed on same amount of substrate and the experimental data
was merged before database searching. Initial protein/peptide identification
from LC-MS/MS data was done using the Mascot search engine (Matrix
Science, version 2.2.04; www.matrixscience.com), the NCBI (National Library
of Medicine, NIH), and IPI (International Protein Index, EBI, Hinxton, UK) data-
bases. Two missed tryptic cleavage sites were allowed; precursor ion mass
tolerance = 10 ppm, fragment ion mass tolerance = 0.8 Da; peptide variable
modifications were allowed for methionine oxide, cysteine acrylamide, and61–371, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 369
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using significance threshold score p < 0.01. Identified peptide counts (spectral
counts) and percent sequence coverage were then imported to Scaffold
Proteome Software (www.proteomesoftware.com, version 2.05) for further
analysis. Since we started with the same amount of protein, the % sequence
coverage indicating the percentage of the entire length of the protein that was
represented by all the identified tryptic peptides combined was very similar for
each time point. For relative quantification based on number of MS/MS
spectra (Asara et al., 2008) (spectral count) collected, we utilized peptide iden-
tification probability at 90% setting to extract the spectral count for each of the
phosphotyrosine containing peptides spanning YJM1, YJM2 and Yact sites.SUPPLEMENTAL INFORMATION
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